Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339545 · ClinicalTrials.gov registry record
Coronary Flow Reserve Following Orbital Atherectomy
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 15
- Enrollment target
NCT02339545: Completed study, sponsored by Abbott Medical Devices.
NCT02339545 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02339545 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of the study was to evaluate coronary artery flow reserve (CFR) following successful percutaneous coronary intervention (PCI) treatment of severely calcified coronary lesions by orbital atherectomy and stenting.
Primary Outcome
CFR was measured after successful percutaneous coronary intervention (PCI) treatment of severely calcified coronary lesions. It was calculated from coronary blood flow velocity measurements, which were derived from Doppler-velocity wire data recorded in real time. The CFR formula utilized was APVp/APVb, where APVb is the average peak velocity at baseline and APVp is peak hyperemia.
Interventions
- DEVICE Coronary Orbital Atherectomy plus Stenting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-05 |
What the finished NCT02339545 record still lists
NCT02339545 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Coronary Orbital Atherectomy plus Stenting is the first listed.
NCT02339545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02339545 about?
NCT02339545 is a clinical study titled "Coronary Flow Reserve Following Orbital Atherectomy". The purpose of the study was to evaluate coronary artery flow reserve (CFR) following successful percutaneous coronary intervention (PCI) treatment of severely calcified coronary lesions by orbital atherectomy and stenting.
What is the current status of trial NCT02339545?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2015-02. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02339545?
The interventions under investigation include: Coronary Orbital Atherectomy plus Stenting (DEVICE).
Who is sponsoring clinical trial NCT02339545?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia